The cambridge peanut allergy clinic: Real world safety and efficacy outcomes during oral immunotherapy with characterised peanut flour

被引：0
|
作者：
Clark, A. [1 ]
Zolkipli, Q. [1 ]
Ewan, P. [1 ]
机构：
[1] Cambridge Univ Hosp, Cambridge, England
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OA0022
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [41] Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy
    Nilsson, Caroline
    Scurlock, Amy M.
    Dellon, Evan S.
    Brostoff, Joshua M.
    Pham, Trinh
    Ryan, Robert
    Brown, Kari R.
    Adelman, Daniel C.
    Aceves, Seema S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4496 - 4501
  • [42] Peanut vs Other Food Oral Immunotherapy: Trends from an Outpatient Allergy Clinic in Boise, ID
    Monje, Kahlil
    Sadegh, Mojtaba
    Talreja, Neetu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB122 - AB122
  • [43] Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies
    Begin, P.
    Sussman, G.
    Beyer, K.
    Oriel, R. C.
    Ford, L.
    Shreffler, W.
    Campbell, D. E.
    Green, T. D.
    Mukherjee, R.
    Fleischer, D. M.
    ALLERGY, 2020, 75 : 49 - 50
  • [44] Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy
    Jara, Michele
    Walker, Ekaterina
    Tilles, Stephen
    Anagnostou, Aikaterini
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (06) : 778 - 780
  • [45] Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome
    Anagnostou, K.
    Clark, A.
    King, Y.
    Islam, S.
    Deighton, J.
    Ewan, P.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (09): : 1273 - 1281
  • [46] Real-world adoption of FDA-approved peanut oral immunotherapy with palforzia
    Patrawala, Sara
    Ramsey, Allison
    Capucilli, Peter
    Tuong, Linh-An
    Vadamalai, Karthik
    Mustafa, S. Shahzad
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (04): : 1120 - +
  • [47] Identifying candidates for real-world peanut oral immunotherapy: eligibility and barriers to participation
    Blackman, A.
    Anagnostou, A.
    ALLERGY, 2021, 76 : 353 - 353
  • [48] Pooled Analysis Of Long-term Immunological And Safety Outcomes Of Daily Oral Immunotherapy For Peanut Allergy Up To ∼5 Years
    Bird, J. Andrew
    Nilsson, Caroline
    Pham, Trinh
    Tilles, Stephen
    Brown, Kari
    Du Toit, George
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB120 - AB120
  • [49] At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy
    Jones, Stacie M.
    Vickery, Brian P.
    Bird, J. Andrew
    Spergel, Jonathan M.
    Rachid, Rima A.
    Assa'ad, Amal H.
    Wang, Julie
    Leonard, Stephanie A.
    Laubach, Susan Stefanac
    Kim, Edwin
    Davis, Benjamin P.
    Welch, Michael
    Heimall, Jennifer
    Cianferoni, Antonella
    MacGinnitie, Andrew J.
    Crestani, Elena
    Radwan, Amr
    Vereda, Andrea
    Adelman, Daniel C.
    Burks, A. Wesley
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB256 - AB256
  • [50] Oral immunotherapy for peanut allergy A potentially important advance, but long term effectiveness and safety need to be established
    Sheikh, Aziz
    Venderbosch, Iris
    Nurmatov, Ulugbek
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 340
12345